. Empagliflozin reduces brain pathology in Alzheimer's disease and type 2 diabetes. Neural Regen Res. 2024 Jun 1;19(6):1189-1190. Epub 2023 Sep 22 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.